Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ketorolac - Neumentum

Next Previous
Search
Drug Profile

Ketorolac - Neumentum

Alternative Names: Ketorolac (PMB); Ketorolac (PMC); Ketorolac pre mixed bag; Ketorolac tromethamine - Neumentum; NTM 001; NTM 002; NTM 003; Toradol - Neumentum

Latest Information Update: 21 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Neumentum
  • Developer Mayo Clinic; Neumentum; Nuance Biotech
  • Class 2 ring heterocyclic compounds; Carboxylic acids; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyrroles; Small molecules
  • Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Osteoarthritis; Postoperative pain

Most Recent Events

  • 28 Feb 2025 Neumentum plans a phase II trial for Postoperative pain in USA (PO)(NCT06853327)
  • 06 Sep 2024 NEMA Research completes a phase III trial in Postoperative pain (In adults) in the US (IV, Infusion) (NCT05324358)
  • 28 Jul 2023 Phase-III clinical trials in Osteoarthritis (Treatment-experienced) in USA (Intra-articular) (NCT05992883)

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top